Search

Cobalamin

Nitrous acid

Nitrous acid (as sodium nitrite) is used as part of an intravenous mixture with sodium thiosulfate to treat cyanide poisoning. It is on the World Health Organization's List of Essential Medicines, a list of the most important medications...

Fluocinolone acetonide

[T358] This type of device containing fluocinolone acetonide was developed by Taro Pharmaceuticals and approved by FDA in May 2016.[L4676]

Technetium Tc-99m nofetumomab merpentan

[FDA label] Tc-99m nm was developed by Boehringer Ingelheim Pharma KG and FDA approved on September 14, 1992. … It was after discontinued on August 13, 2013, but in the 2018 FDA submission list, it can be found as a substance type II (Drug substance) with an active status.[L1650, L1082]

Pomalidomide

FDA approved on February 8, 2013.

Calcium phosphate dihydrate

Pralnacasan

Pralnacasan is an orally bioavailable pro-drug of a potent, non-peptide inhibitor of interleukin-1beta converting enzyme (ICE).

Teclistamab

[L43612] Teclistamab was later granted accelerated approval by the FDA on October 25, 2022.[L43617]

Dolutegravir

[A31342] Dolutegravir was developed by ViiV Healthcare and FDA-approved on August 12, 2013.

Capivasertib

[A262021,A262026,A262031] On November 17th, 2023, capivasertib, under the brand name TRUQAP, was approved by the FDA for the treatment of adult patients HR-positive, HER2-negative locally advanced or